Dogwood Therapeutics, Inc.
DWTX
$5.37
$1.1025.76%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 14.85M | 2.04M | 3.02M | 2.38M | 3.32M |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 832.90K | 211.40K | 389.50K | 541.90K | 711.10K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 863.60K | 32.00K | 226.20K | 303.20K | 137.40K |
Total Current Assets | 16.54M | 2.28M | 3.64M | 3.22M | 4.17M |
|
|||||
Total Current Assets | 16.54M | 2.28M | 3.64M | 3.22M | 4.17M |
Net Property, Plant & Equipment | 222.60K | -- | -- | -- | -- |
Long-term Investments | 11.81M | -- | -- | -- | -- |
Goodwill | 11.81M | -- | -- | -- | -- |
Total Other Intangibles | 65.71M | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 18.10K | -- | -- | -- | -- |
Total Assets | 94.31M | 2.28M | 3.64M | 3.22M | 4.17M |
|
|||||
Total Accounts Payable | 1.23M | 455.00K | 217.80K | 196.80K | 111.90K |
Total Accrued Expenses | 1.89M | 878.90K | 282.30K | 373.30K | 246.60K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 49.70K | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 3.18M | 1.33M | 500.10K | 570.10K | 358.50K |
|
|||||
Total Current Liabilities | 3.18M | 1.33M | 500.10K | 570.10K | 358.50K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 154.90K | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 26.70M | -- | -- | -- | -- |
Total Liabilities | 30.03M | 1.33M | 500.10K | 570.10K | 358.50K |
|
|||||
Common Stock & APIC | 67.86M | 67.34M | 67.25M | 65.71M | 65.58M |
Retained Earnings | -73.82M | -66.09M | -63.81M | -62.76M | -61.47M |
Treasury Stock & Other | -4.16M | -299.10K | -299.10K | -299.10K | -299.10K |
Total Common Equity | -10.12M | 949.40K | 3.14M | 2.65M | 3.81M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 74.41M | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 74.41M | -- | -- | -- | -- |
|
|||||
Total Common Equity | -10.12M | 949.40K | 3.14M | 2.65M | 3.81M |
Total Preferred Equity | 74.41M | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 64.28M | 949.40K | 3.14M | 2.65M | 3.81M |
|